Biohaven BHVN Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -333%-22.2pp | -310.8%— | —— | -295.9%+20.9pp | -316.8%-118pp | |
| Return on invested capital | -395.4%-72.3pp | -323.1%+110pp | -433.6%-59.4pp | -374.2%+173pp | -547.4%-234pp | |
| Liquidity | ||||||
| Current ratio | 7.4×+4.2× | 3.2×+0.3× | 2.9×-1.0× | 3.8×+1.5× | 2.3×-1.2× | |
| Leverage | ||||||
| Debt-to-equity | 2.2×-3.3× | 5.5×— | —— | 2.2×+2.0× | 0.1×+0.1× | |
| Per Share | ||||||
| Book value per share | $0.88+81.3% | $0.48+398% | -$0.16-112% | $1.31-48.4% | $2.55-45.2% | |
| Valuation | ||||||
| Market capitalization | $1.27B-15.1% | $1.5B-5.7% | $1.59B+5.3% | $1.51B-38.5% | $2.45B-35.0% | |
| Price / book | 9.8×-18.9× | 28.8×— | —— | 11.2×+1.8× | 9.5×+0.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Biohaven's ratios come from?
- Every ratio is computed from Biohaven's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.